top of page
Search
A Look at the Generic and Biosimilar Drug Pipeline
IPD Analytics discussed both the generic and biosimilar drugs coming to market, and implications for managed care pharmacy at AMCP eLearning
Apr 20, 2020
AMCP Presenters Predict 4 More Biosimilar Launches in 2020
The pace of clinical trials have been affected by COVID-19, according to IPD Analytics' experts on the pharmaceutical pipeline.
Apr 20, 2020
Express Scripts Coverage, FDA Label Update Boost Rybelsus
There is some difference in opinion regarding how payers will set their formulary management strategy on GLP-1's.
Jan 23, 2020
bottom of page